Research Article

Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients

Table 2

Risk factors for mortality of patients in univariate/multivariate Cox proportional hazards models.

FactorNumber ()Deaths ()UnivariateMultivariate
HR95% CIHR95% CI

Sex0.817
Male441 (87.3)74 (16.8)1.00.9–1.1
Female64 (12.7)10 (15.6)1
Age (years)0.020
<30123 (24.4)12 (9.8)1
≥30382 (75.6)72 (18.8)2.11.1–3.8
BMI (kg/m2)
Missing data37 (7.3)22 (59.5)
<18110 (21.8)21 (19.1)1.81.0–3.00.036
≥18358 (70.9)41 (11.5)1
WHO stage<0.0010.008
I/II/III217 (43.0)19 (8.8)1.01.0
IV288 (57.0)65 (22.6)5.63.0–10.52.91.3–6.5
CD4 count (cells/μL)<0.0010.007
Missing data71 (14.1)15 (21.1)
<50181 (35.8)45 (24.9)3.01.8–4.92.41.3-4.4
≥50253 (50.1)24 (9.5)11
Serum sodium (mmol/L)0.002
Missing data42 (8.3)5 (11.9)
<13028 (5.5)10 (35.7)1
≥130435 (86.1)69 (15.9)2.91.5–5.6
Hemoglobin (g/L)0.035
Missing data33 (6.5)4 (12.1)
<110166 (32.9)37 (22.3)1.61.0–2.5
≥110306 (60.6)43 (11.7)1
Serum albumin (g/L)<0.001
<35237 (46.9)60 (25.3)3.22.0–5.2
≥35268 (53.1)24 (9.0)1.0
Serum BChE (U/L)<0.0010.035
≥4500376 (74.5)42 (11.2)11
<4500129 (25.5)42 (32.6)3.52.3–5.31.81.0–3.2

BChE: butyrylcholinesterase; BMI: body mass index; HR: hazard ratio; WHO: World Health Organization.